Re: So, coronavirus...
Posted: Thu May 27, 2021 6:52 pm
Yeah, he's type 1 from memory
Margin__Walker wrote: ↑Thu May 27, 2021 7:25 pm Another good thread on the Indian variant from John Burn-Murdoch
He seems to have decided that things he's unaware of or doesn't understand simply don't exist. Mad.There is no way of knowing what it could do... I just think there hasn't been any where near enough testing to deem it safe.
What exactly is he expecting to suddenly jump out after 6 months and hundreds of millions of doses?sockwithaticket wrote: ↑Thu May 27, 2021 7:45 pm I've seen the article text on reddit, these are the two key lines of quote for me:
He seems to have decided that things he's unaware of or doesn't understand simply don't exist. Mad.There is no way of knowing what it could do... I just think there hasn't been any where near enough testing to deem it safe.
If I were a coach from another team; I wouldn't be happy with my players attending an England camp with him either. Even being in a ruck, during a game, with him could be enough to infect someone else.
Raggs wrote: ↑Thu May 27, 2021 7:50 pmWhat exactly is he expecting to suddenly jump out after 6 months and hundreds of millions of doses?sockwithaticket wrote: ↑Thu May 27, 2021 7:45 pm I've seen the article text on reddit, these are the two key lines of quote for me:
He seems to have decided that things he's unaware of or doesn't understand simply don't exist. Mad.There is no way of knowing what it could do... I just think there hasn't been any where near enough testing to deem it safe.
Where's Bridlington?Margin__Walker wrote: ↑Thu May 27, 2021 6:53 pm Tons of them down at Exeter (Williams, Hepburn, Nowell etc). Something in the water I reckon.
That's why it doesn't make sense to withhold vaccines from poorer countries which will incubate ever more resistant forms.Saint wrote: ↑Thu May 27, 2021 7:35 pmMargin__Walker wrote: ↑Thu May 27, 2021 7:25 pm Another good thread on the Indian variant from John Burn-Murdoch
Yeah - I suspect the final unlock will be have to be delayed a bit to let vax rollout reach a wider population. Probably only talking about a couple of weeks or so
Not sure what point you're making? No-one is sitting on a stockpile of vaccineRinkals wrote: ↑Fri May 28, 2021 5:24 amThat's why it doesn't make sense to withhold vaccines from poorer countries which will incubate ever more resistant forms.Saint wrote: ↑Thu May 27, 2021 7:35 pmMargin__Walker wrote: ↑Thu May 27, 2021 7:25 pm Another good thread on the Indian variant from John Burn-Murdoch
Yeah - I suspect the final unlock will be have to be delayed a bit to let vax rollout reach a wider population. Probably only talking about a couple of weeks or so
Well, I guess it may make sense financially, though, TBF.
They may not be sitting on stockpiles, but they are making them unaffordable.Saint wrote: ↑Fri May 28, 2021 6:01 amNot sure what point you're making? No-one is sitting on a stockpile of vaccine
It’s availability, not affordability, that’s the problem. There’s billions sitting in COVAX unspent as they’re not available.
Yes but Israel will get vaccines before Palestine. New Zealand will get vaccines before Uganda. Just how the world is.
Yeah, it is. Somewhere is going to get it first and any country that produces vaccine will give it to their own citizens first. New Zealand currently has less than 10% of people with one dose btw. Uganda has more people having had at least one dose than NZ (570k vs 340k).FalseBayFC wrote: ↑Fri May 28, 2021 7:37 amYes but Israel will get vaccines before Palestine. New Zealand will get vaccines before Uganda. Just how the world is.
https://sacoronavirus.co.za/2021/01/03/ ... -strategy/
https://www.sanews.gov.za/south-africa/ ... e-vaccinesSouth Africa has world-class clinical, sociological, epidemiological, and laboratory research expertise, and this has been the basis of the development of a wide-ranging research agenda for COVID-19 including vaccine development. The South African government is supporting the efforts of South African research institutions and vaccine manufacturing sites to conduct and contribute to research to accelerate the development and manufacture of promising COVID-19 vaccines and treatments. In addition, research institutions and manufacturing sites have partnered with international vaccine manufacturers and research allowing the country to make significant contributions to vaccine development efforts.
https://theconversation.com/vaccine-pro ... ped-153204Nzimande told the media on Monday that government, through the Department of Science and Innovation (DSI), owns a 47.5% stake in Biovac, a biopharmaceutical company.
“The company has over the years developed the capability to manufacture vaccines,” he said.
Last year, the Minister launched an initiative, which sees Biovac manufacturing Hexaxim in partnership with Sanofi.
Hexaxim is the world's first liquid hexavalent vaccine that protects against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenza type B, and poliomyelitis.
“So, we do have a foundation that we need to build on,” he stressed.
As far as I can see, it's the issue of Intellectual Property which is preventing Countries from having a free hand in producing vaccines.India illustrates this well. The Serum Institute of India, a privately owned pharmaceutical company, is manufacturing large quantities of the University of Oxford/AstraZeneca and Novavax COVID-19 vaccines. The company scheduled to reach 100 million doses produced a month by March 2021. In return, India will keep a portion of the vaccines it manufactures – reportedly 100 million doses in the first instance.
Good on them.Paddington Bear wrote: ↑Fri May 28, 2021 7:30 amThe UK explicitly isn't and has produced a vaccine at cost.
Which is why the AZ vaccine has been licenced for production by the Serum Institute of India and I believe partners in SA as wellRinkals wrote: ↑Fri May 28, 2021 8:05 amGood on them.Paddington Bear wrote: ↑Fri May 28, 2021 7:30 amThe UK explicitly isn't and has produced a vaccine at cost.
However, 'at cost' in the UK is probably significantly more expensive than it is in India or South Africa.
Provided they all end up at a sporting event, concert, restaurant or pub they should be OK.
Not sure that New Zealand, Australia, Canada and most European countries manufacture the vaccines they are administering.Biffer wrote: ↑Fri May 28, 2021 7:50 amYeah, it is. Somewhere is going to get it first and any country that produces vaccine will give it to their own citizens first. New Zealand currently has less than 10% of people with one dose btw. Uganda has more people having had at least one dose than NZ (570k vs 340k).FalseBayFC wrote: ↑Fri May 28, 2021 7:37 amYes but Israel will get vaccines before Palestine. New Zealand will get vaccines before Uganda. Just how the world is.
Aspen Pharma have partnered with J&J to produce their vaccine in SA. Bio vac are partnering with a US company to produce vaccine as well. But you can’t just snap your fingers and suddenly produce these vaccines - most of them are a different technology to what’s currently done in SA. Look at how long it took the EU to get their manufacturing plants up and running. SII took a long time to get up to current levels as well, and they’re a longer established facility used to producing at scale. There’s a limited number of people who understand the scale up process.Rinkals wrote: ↑Fri May 28, 2021 8:01 amhttps://sacoronavirus.co.za/2021/01/03/ ... -strategy/https://www.sanews.gov.za/south-africa/ ... e-vaccinesSouth Africa has world-class clinical, sociological, epidemiological, and laboratory research expertise, and this has been the basis of the development of a wide-ranging research agenda for COVID-19 including vaccine development. The South African government is supporting the efforts of South African research institutions and vaccine manufacturing sites to conduct and contribute to research to accelerate the development and manufacture of promising COVID-19 vaccines and treatments. In addition, research institutions and manufacturing sites have partnered with international vaccine manufacturers and research allowing the country to make significant contributions to vaccine development efforts.https://theconversation.com/vaccine-pro ... ped-153204Nzimande told the media on Monday that government, through the Department of Science and Innovation (DSI), owns a 47.5% stake in Biovac, a biopharmaceutical company.
“The company has over the years developed the capability to manufacture vaccines,” he said.
Last year, the Minister launched an initiative, which sees Biovac manufacturing Hexaxim in partnership with Sanofi.
Hexaxim is the world's first liquid hexavalent vaccine that protects against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenza type B, and poliomyelitis.
“So, we do have a foundation that we need to build on,” he stressed.As far as I can see, it's the issue of Intellectual Property which is preventing Countries from having a free hand in producing vaccines.India illustrates this well. The Serum Institute of India, a privately owned pharmaceutical company, is manufacturing large quantities of the University of Oxford/AstraZeneca and Novavax COVID-19 vaccines. The company scheduled to reach 100 million doses produced a month by March 2021. In return, India will keep a portion of the vaccines it manufactures – reportedly 100 million doses in the first instance.
India's production is under licence, which obviously carries a financial burden.
It's not that vaccines cannot be produced there, it's that the cost of licenses makes it uneconomic.
Which is my whole point.
If you want to eradicate this disease, poor people need to be inoculated as well.
Otherwise the virus can incubate ever more resistant strains. Which may be beneficial to the industry.
Hopefully it will be different for the next pandemic. I firmly believe putting national interest first is what made this such a mess. A little more co-operation between nations would have made a big difference hereBiffer wrote: ↑Fri May 28, 2021 10:12 am For Europe, the EU is one country wrt vaccine provision. The others are fundamentally money talks, which is shit, no argument from me. But do you seriously expect a National government to step aside and say they won’t do their best to protect their own citizens?
Dai Lama on Twitter suggesting it’s a clever ploy to always pass an HIA as this is now his baseline.
If the poorer nations are not capable of producing vaccines (something which may be in dispute), then why is a moratorium on the IP out of the question? At the very least any licence to produce the vaccine should be at no cost.Biffer wrote: ↑Fri May 28, 2021 10:20 amAspen Pharma have partnered with J&J to produce their vaccine in SA. Bio vac are partnering with a US company to produce vaccine as well. But you can’t just snap your fingers and suddenly produce these vaccines - most of them are a different technology to what’s currently done in SA. Look at how long it took the EU to get their manufacturing plants up and running. SII took a long time to get up to current levels as well, and they’re a longer established facility used to producing at scale. There’s a limited number of people who understand the scale up process.Rinkals wrote: ↑Fri May 28, 2021 8:01 amhttps://sacoronavirus.co.za/2021/01/03/ ... -strategy/https://www.sanews.gov.za/south-africa/ ... e-vaccinesSouth Africa has world-class clinical, sociological, epidemiological, and laboratory research expertise, and this has been the basis of the development of a wide-ranging research agenda for COVID-19 including vaccine development. The South African government is supporting the efforts of South African research institutions and vaccine manufacturing sites to conduct and contribute to research to accelerate the development and manufacture of promising COVID-19 vaccines and treatments. In addition, research institutions and manufacturing sites have partnered with international vaccine manufacturers and research allowing the country to make significant contributions to vaccine development efforts.https://theconversation.com/vaccine-pro ... ped-153204Nzimande told the media on Monday that government, through the Department of Science and Innovation (DSI), owns a 47.5% stake in Biovac, a biopharmaceutical company.
“The company has over the years developed the capability to manufacture vaccines,” he said.
Last year, the Minister launched an initiative, which sees Biovac manufacturing Hexaxim in partnership with Sanofi.
Hexaxim is the world's first liquid hexavalent vaccine that protects against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenza type B, and poliomyelitis.
“So, we do have a foundation that we need to build on,” he stressed.As far as I can see, it's the issue of Intellectual Property which is preventing Countries from having a free hand in producing vaccines.India illustrates this well. The Serum Institute of India, a privately owned pharmaceutical company, is manufacturing large quantities of the University of Oxford/AstraZeneca and Novavax COVID-19 vaccines. The company scheduled to reach 100 million doses produced a month by March 2021. In return, India will keep a portion of the vaccines it manufactures – reportedly 100 million doses in the first instance.
India's production is under licence, which obviously carries a financial burden.
It's not that vaccines cannot be produced there, it's that the cost of licenses makes it uneconomic.
Which is my whole point.
If you want to eradicate this disease, poor people need to be inoculated as well.
Otherwise the virus can incubate ever more resistant strains. Which may be beneficial to the industry.
That's not "making it unaffordable "Rinkals wrote: ↑Fri May 28, 2021 8:05 amGood on them.Paddington Bear wrote: ↑Fri May 28, 2021 7:30 amThe UK explicitly isn't and has produced a vaccine at cost.
However, 'at cost' in the UK is probably significantly more expensive than it is in India or South Africa.
Then what’s the point of the moratorium? If you do that and then give absolutely no assistance in understanding what’s required in scaling up, then it’s just empty gesture politics. And you’d inevitably end up with another group saying, ‘you’ve got the info, sort yourself out’ and supplying nothing to developing countries. As can be seen in a few countries, build up of vaccine production facilities is starting, it’ll continue over the next year or so. We are going to need billions of these every year for a good few years. More production plants are needed but you can’t set them up in a few weeks. It’s astonishing we’ve got so much being produced already.Rinkals wrote: ↑Fri May 28, 2021 10:50 amIf the poorer nations are not capable of producing vaccines (something which may be in dispute), then why is a moratorium on the IP out of the question? At the very least any licence to produce the vaccine should be at no cost.Biffer wrote: ↑Fri May 28, 2021 10:20 amAspen Pharma have partnered with J&J to produce their vaccine in SA. Bio vac are partnering with a US company to produce vaccine as well. But you can’t just snap your fingers and suddenly produce these vaccines - most of them are a different technology to what’s currently done in SA. Look at how long it took the EU to get their manufacturing plants up and running. SII took a long time to get up to current levels as well, and they’re a longer established facility used to producing at scale. There’s a limited number of people who understand the scale up process.Rinkals wrote: ↑Fri May 28, 2021 8:01 am
https://sacoronavirus.co.za/2021/01/03/ ... -strategy/
https://www.sanews.gov.za/south-africa/ ... e-vaccines
https://theconversation.com/vaccine-pro ... ped-153204
As far as I can see, it's the issue of Intellectual Property which is preventing Countries from having a free hand in producing vaccines.
India's production is under licence, which obviously carries a financial burden.
It's not that vaccines cannot be produced there, it's that the cost of licenses makes it uneconomic.
Which is my whole point.
If you want to eradicate this disease, poor people need to be inoculated as well.
Otherwise the virus can incubate ever more resistant strains. Which may be beneficial to the industry.
Look, I understand the premise that the companies that spent decades developing these vaccines should be able to profit from them, but I just think that allowing the virus to incubate and develop resistant strains outside of the wealthy nations who have funded the research is short sighted. Or maybe long-sighted depending on whether your only objective is profit.
But it also shows that Bimbot is a dickhead when he claimed that the virus only kills old people. Lots of new admissions in the 30-39 age group in serious condition.
Now that we have a more virulent version of the virus dominant and spreading fast it would be sensible to not lift lockdown in June and try and get ahead with the vaccination programme. Whilst younger folk are a lot less likely to die of covid19, if we lift lockdown now we will just see lots and lots of cases and after that it's a numbers game - a % will need hospitalisation and a % of them will die. There is also the no small matter of long covid and possibly consigning young folk to many weeks or months of potentially serious ongoing health problems. With schools/colleges back and no plans to vaccinated u16s then we have an ideal environment in schools and colleges for the virus to spread asymptomatically across the wider community. It would make more sense to retain current lock down arrangements until schools finish up?Sandstorm wrote: ↑Fri May 28, 2021 12:50 pmBut it also shows that Bimbot is a dickhead when he claimed that the virus only kills old people. Lots of new admissions in the 30-39 age group in serious condition.
I suspect they were careful for a year to keep Mum and Grandad safe. Soon as the elderly got jabbed, their grown up kids forgot all about restrictions and started socialising all over. Plus back to school for their own children....